EGFR and non-small cell lung carcinoma: Up to 57.9% of NSCLC patients with EGFR mutations were identified in an Asian cohort, [23] and the frequencies of EGFR mutations in non-Asian cohorts ranged from 7.0% to 33.2% [24–26].